Holen Sie sich die Stockscreener-App
1.88
0.53%
0.010
Handel nachbörslich:
1.95
0.07
+3.72%
Schlusskurs vom Vortag:
$1.87
Offen:
$1.86
24-Stunden-Volumen:
44,601
Relative Volume:
0.03
Marktkapitalisierung:
$4.90M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-15.70%
1M Leistung:
-27.41%
6M Leistung:
-25.10%
1J Leistung:
+0.00%
1-Tages-Spanne:
$1.86
$1.9463
1-Wochen-Bereich:
$1.83
$2.2299
52-Wochen-Spanne:
$1.41
$5.30
Vivosim Labs Inc Stock (VIVS) Company Profile
Firmenname
Vivosim Labs Inc
Sektor
Branche
Telefon
858-224-1000
Adresse
11555 SORRENTO VALLEY ROAD, SAN DIEGO
Compare VIVS vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VIVS
Vivosim Labs Inc
|
1.88 | 4.88M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Vivosim Labs Inc Stock (VIVS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2018-12-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-11-10 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2017-01-25 | Eingeleitet | Raymond James | Outperform |
| 2015-08-11 | Herabstufung | Cantor Fitzgerald | Buy → Hold |
| 2015-06-29 | Eingeleitet | Jefferies | Buy |
| 2015-06-29 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Vivosim Labs Inc Aktie (VIVS) Neueste Nachrichten
VIVS Earnings History & Surprises | EPS & Revenue Results | VIVOSIM LABS INC (NASDAQ:VIVS) - ChartMill
VivoSim names Raghunathan as VP of global sales By Investing.com - Investing.com Australia
VivoSim names Raghunathan as VP of global sales - Investing.com
Vivosim appoints Arumugham (Ragoo) Raghunathan as vice president of global sales - marketscreener.com
VivoSim Appoints Arumugham (Ragoo) Raghunathan as Vice President of Global Sales - GlobeNewswire
VIVS Should I Buy - Intellectia AI
VIVS Technical Analysis & Stock Price Forecast - Intellectia AI
Exit Recap: Is VivoSim Labs Inc showing insider buying2025 Trading Volume Trends & Weekly Chart Analysis and Guides - baoquankhu1.vn
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Travel Stocks: Does VivoSim Labs Inc have pricing powerJuly 2025 Patterns & Long-Term Capital Growth Ideas - baoquankhu1.vn
Rate Cut: Is VivoSim Labs Inc showing insider buyingQuarterly Market Review & Stock Portfolio Risk Management - baoquankhu1.vn
Sectors Review: Is SmartKem Inc part of any ETFTrade Performance Summary & Low Risk High Win Rate Picks - baoquankhu1.vn
Is VivoSim Labs Inc. benefiting from innovation trends2025 EndofYear Setup & Precise Buy Zone Identification - mfd.ru
Why VivoSim Labs Inc. stock is rated strong buyJuly 2025 Review & Risk Controlled Daily Plans - mfd.ru
Aug Fed Impact: Is LXFRs ROE strong enough2025 Market Sentiment & Stock Market Timing Techniques - baoquankhu1.vn
VIVS Income Statement | VIVOSIM LABS INC (NASDAQ:VIVS) - ChartMill
VivoSim (VIVS) to Present Innovative Data at SOT Meeting - GuruFocus
VivoSim to Debut Antibody Drug Conjugate Data, representing - GlobeNewswire
Shorts Report: Is VivoSim Labs Inc a stock for growth or value investors2025 Big Picture & Low Drawdown Trading Techniques - baoquankhu1.vn
VivoSim to Debut Antibody Drug Conjugate Data, representing a major new market for NAMkind models, at Society of Toxicology Meeting in San Diego - GlobeNewswire
Sentiment Recap: What chart patterns are forming on FTNTShort Setup & Weekly Top Performers Watchlists - baoquankhu1.vn
Aug Mood: Is VivoSim Labs Inc benefiting from innovation trendsQuarterly Market Summary & Pattern Based Trade Signal System - baoquankhu1.vn
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Aug Fed Impact: Is Quest Resource Holding Corporation attractive at current valuationJuly 2025 Opening Moves & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Trend Recap: Does VivoSim Labs Inc have pricing powerJuly 2025 Big Picture & Safe Swing Trade Setups - baoquankhu1.vn
Morning Market Movers: FATN, FIEE, TER, PBM, See Big Swings - RTTNews
Why is VIVS stock up 79% today? - MSN
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Biotech Stocks To Keep An Eye On – January 31st - Defense World
Aug PreEarnings: Is VivoSim Labs Inc showing insider buyingM&A Rumor & Reliable Entry Point Alerts - baoquankhu1.vn
Top Biotech Stocks To Follow TodayFebruary 1st - MarketBeat
VivoSim Labs Leaps 82% Amid Strategic Partnerships in Asia - StocksToTrade
Biotech Stocks To Follow Today – January 30th - Defense World
Biotech Stocks To Keep An Eye OnJanuary 31st - MarketBeat
VivoSim Labs Shares Surge 82% Amid Key Asia Distribution Deals - StocksToTrade
VivoSim Labs Stock Soars After Major Distribution Deals in Asia - timothysykes.com
Biotech Stocks To Follow TodayJanuary 30th - MarketBeat
Why Is VIVS Stock Up 79% Today? - Asianet Newsable
VivoSim Labs, Inc.Common Stock (Nasdaq:VIVS) Stock Quote - The Chronicle-Journal
Top Midday Gainers - marketscreener.com
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Gold Tumbles Over 6%; Apple Posts Upbeat Earnings - Benzinga
VivoSim Labs Expands Amid Global Market Challenges - StocksToTrade
Dow Falls Over 100 Points; Verizon Earnings Top Views - Benzinga
Morning Market Movers: TCGL, VIVS, LRHC, KXIN See Big Swings - RTTNews
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
VivoSim Labs stock (VIVS) jumps premarket after Korea, China distributor deals — what to watch next - TechStock²
Why SanDisk Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket - Benzinga
VivoSim Expands Asia-Pacific Access To NAMKind Toxicology Services; Stock Skyrockets - Nasdaq
Aug Gainers: Will VivoSim Labs Inc benefit from AI trendsMarket Risk Summary & Breakout Confirmation Trade Signals - baoquankhu1.vn
VivoSim Expands Asia-Pacific Access to NAMKind™ Human-Based - GlobeNewswire
Finanzdaten der Vivosim Labs Inc-Aktie (VIVS)
Es liegen keine Finanzdaten für Vivosim Labs Inc (VIVS) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
3.69%
0.68%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):